Proclaim is a technology company.
Proclaim has raised $15.0M across 1 funding round.
Proclaim has raised $15.0M in total across 1 funding round.
Proclaim has raised $15.0M in total across 1 funding round.
Proclaim's investors include AYANA Capital LLC, Bennu, Sonder Capital, Anne Wojcicki, Jim Pallotta, Robert Ciardi, Warren Jenson.
Proclaim is a technology company specializing in advanced at-home oral health systems. Its flagship product is a custom-jet oral irrigator that uses a custom-fit mouthpiece created from a 3D scan of the user’s mouth, delivering a professional-level clean in just 7 seconds. Proclaim serves individuals seeking effective, personalized oral hygiene solutions, addressing the challenge of achieving deep cleaning between teeth and below the gumline more efficiently than traditional flossing or water flossers. Since launching pre-orders in late 2023 and shipping in early 2024, Proclaim has demonstrated strong growth momentum, expanding its dental provider network to over 700 partners nationwide and reducing its product price by over 25% to increase accessibility[1][2][6].
Founded in 2017 and headquartered in Mountain View, California, Proclaim was created by a team of engineers, clinicians, and designers focused on eliminating preventable oral diseases through breakthrough technology. The idea emerged from the need to provide a fully automated, personalized oral care solution that could replicate professional dental cleaning at home. Early traction included clinical validation showing significant reductions in gum disease markers within 30 days and rapid consumer adoption reflected in thousands of units sold shortly after launch[1][2][6].
Proclaim rides the growing trend of personalized, preventative health and wellness technologies, leveraging digital scanning, 3D printing, and fluid dynamics to disrupt traditional oral care. The timing is favorable as consumers increasingly prioritize health maintenance at home, accelerated by advances in digital health and tele-dentistry. Proclaim’s integration with dental professionals and its scalable production capabilities position it to influence the oral health ecosystem by setting new standards for at-home care and reducing preventable oral diseases[2].
Looking ahead, Proclaim is poised to expand its market penetration by continuing to lower costs and grow its dental partner network. Trends such as increased consumer demand for personalized health tech, automation, and remote healthcare solutions will likely shape its trajectory. Its influence may evolve from a niche oral care device to a broader platform for automated, personalized health maintenance, potentially integrating with other digital health ecosystems. Proclaim’s innovation in combining customization, automation, and clinical efficacy offers a compelling model for future health technology products[2][6].
Proclaim has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series B in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2022 | $15.0M Series B | AYANA Capital LLC, Bennu, Sonder Capital, Anne Wojcicki, Jim Pallotta, Robert Ciardi, Warren Jenson |